__timestamp | BioMarin Pharmaceutical Inc. | Novartis AG |
---|---|---|
Wednesday, January 1, 2014 | 751040000 | 53634000000 |
Thursday, January 1, 2015 | 889895000 | 50387000000 |
Friday, January 1, 2016 | 1116854000 | 49436000000 |
Sunday, January 1, 2017 | 1313646000 | 50135000000 |
Monday, January 1, 2018 | 1491212000 | 53166000000 |
Tuesday, January 1, 2019 | 1704048000 | 48677000000 |
Wednesday, January 1, 2020 | 1860455000 | 49898000000 |
Friday, January 1, 2021 | 1846275000 | 52877000000 |
Saturday, January 1, 2022 | 2096039000 | 51828000000 |
Sunday, January 1, 2023 | 2419226000 | 46660000000 |
Monday, January 1, 2024 | 51722000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, revenue generation is a key indicator of a company's market strength and innovation prowess. Over the past decade, Novartis AG and BioMarin Pharmaceutical Inc. have been at the forefront, each carving out a distinct niche. From 2014 to 2023, Novartis AG consistently outperformed BioMarin, generating approximately 30 times more revenue annually. In 2023, Novartis AG reported a revenue of around $46.66 billion, while BioMarin reached $2.42 billion, marking a significant growth of over 220% for BioMarin since 2014. This trend highlights Novartis's dominance in the global market, yet underscores BioMarin's impressive growth trajectory in the biotech sector. As the industry evolves, these figures not only reflect past achievements but also set the stage for future innovations and market dynamics.
Revenue Showdown: Eli Lilly and Company vs Novartis AG
Merck & Co., Inc. and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Novartis AG vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Novartis AG or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Novartis AG vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Novartis AG or Lantheus Holdings, Inc.
Comparing Revenue Performance: Novartis AG or HUTCHMED (China) Limited?
Who Generates More Revenue? Dr. Reddy's Laboratories Limited or BioMarin Pharmaceutical Inc.
Revenue Insights: BioMarin Pharmaceutical Inc. and ACADIA Pharmaceuticals Inc. Performance Compared
Revenue Showdown: BioMarin Pharmaceutical Inc. vs Vericel Corporation
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Generates More Revenue? BioMarin Pharmaceutical Inc. or Travere Therapeutics, Inc.